What Is the Relationship Between an FDA HDE (Humanitarian Device Exemption) & HUD (Humanitarian Use Device) - or are They the Same?

Event Information
Product Format
Prerecorded Event
60 Minutes
Product Description

Insights on Sponsor, Investigator and IRB Responsibilities for Managing a Device that has Received FDA HUD Approval

Even though Humanitarian Device Exemption (HDEs) and Humanitarian Use Device approvals (HUDs) have been around for many years, due to the few number of device indications that are actually designated as an HDE and subsequently receive HUD approval, most research professionals have little to no knowledge of the differences between the two terms or understand how they are operationalized in a real world setting.

In this session, Lee Truax-Bellows will provide you with a working knowledge of what each term means and a basic understanding of Sponsor, Investigator and IRB responsibilities for managing a device that has received FDA HUD approval.

Confusion on what an HDE designation and HUD approval means and how it impacts Sponsors, Investigators and IRBs is prevalent throughout the research community. This session will assist the participant in identifying and defining the two terms. Lee will discuss the responsibilities of each of the three parties that manage HUD, i.e., the Sponsor, IRBs and Site Investigators. A lecture format provided through a PowerPoint presentation will be used to educate the participant. A discussion of the final FDA Guidance titled “Guidance for HDE Holders, Institutional Review Boards (IRBs), Clinical Investigators”, and both the current and newly revised draft version of “FDA Staff - Humanitarian Device Exemption (HDE) Regulation: Questions and Answers” will be included as part of the presentation.

In this 60 minute session, Lee will discuss:

  • FDA Guidance Documents
    • FDA Final Guidance Humanitarian Use Device (HUD) Designations Jan 24, 2013
    • FDA Final Guidance Humanitarian Device Exemption (HDE) Regulation: Questions and Answers July 08, 2010
    • FDA DRAFT Guidance Humanitarian Device Exemption (HDE): Questions and Answers March 18, 2014

At the end of this webinar participants will be able to:

  • Define an HDE and an HUD.
  • Describe the basic process for obtaining HDE designation and HUD approval.
  • Describe Sponsor responsibilities under an HUD approval.
  • Describe IRB responsibilities under an HUD approval.
  • Describe Clinical Investigator responsibilities under an HUD approval.

Who should attend

  • Device professionals at the site, IRB and sponsor level
  • Monitors
  • Project Managers
  • Clinical Investigators
  • Study Coordinators
  • IRB Members

Order Below or Call 1-866-458-2965 Today

Order Form

(Select the format below)

Choose Quantity:

(*) Single User Price

You can also order through:




About Our Speaker

Lee Truax Bellows  - Biotech Training Expert

Lee Truax-Bellows is a founder, President and CEO of Norwich Clinical Research Associates Ltd. (NCRA).  NCRA is a full service clinical contract research organization (CRO) based in upstate NY.  

Lee has an extensive background in the pharmaceutical and medical device industries, having worked for both industry and a CRO as a Monitor, Medical Communications Associate, Project Manager, Senior Quality Auditor, Senior Trainer, and Regulatory...   More Info
More Events By The Speaker

Why AudioEducator?
  • Save money on travel.
  • Meet your specific training needs.
  • Keep learning after the event.
  • Save time training your whole staff.
Join Our Mailing List
Our Accreditation Partners
Facebook Twitter Linkedin Youtube RSS Feeds Google Plus